Official Title
Study for Clinical Epidemiology and Methods of Diagnosis and Treatment of Novel Coronavirus Pneumonia (NCP)
Brief Summary

To develop practical and effective clinical diagnosis and treatment schemes for the control of novel coronavirus pneumonia.

Detailed Description

By retrospectively analyzing the clinical epidemiological characteristics of the novel
coronavirus pneumonia and the current diagnosis and treatment schemes, as well as in-depth
analyzing the disease development process and outcome trends of NCP patients to develop
practical and effective clinical diagnosis and treatment schemes and provide guarantee for
the rapid control of the epidemic.

Unknown status
Novel Coronavirus Pneumonia

Combination Product: systemic treatment

Oxygen therapy, antiviral therapy, antibiotics, hormones, globulin

Eligibility Criteria

Inclusion Criteria:

- Patients confirmed with novel coronavirus pneumonia. The Diagnostic criteria refer to
"Pneumonitis Diagnosis and Treatment Scheme for Novel Coronavirus Infection (Trial
Version 5)";

Exclusion Criteria:

- Physician judged the patient was not suitable for this clinical trial.

Eligibility Gender
Eligibility Age
Minimum: 18 Years ~ Maximum: 90 Years

Union hospital
Wuhan, Hubei, China

Investigator: Yang Jin
Contact: 13554361146


Yang Jin

Jiancai Wu

Wuhan Union Hospital, China
NCT Number
MeSH Terms
Coronavirus Infections